GlassScriptPhysician profile
Elizabeth Solano
NPI 1275544157
$1,738.53
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,675 · 2020: $33.24 · 2021: $16.97 · 2023: $13.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $509.90 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $196.77 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.02 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $159.86 | 2019 | |
| Glaxosmithkline, LLC. | $146.73 | 2019 | |
| Amgen INC. | $117.42 | 2019 | |
| Pfizer INC. | $85.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $81.91 | 2019 | |
| Lilly USA, LLC | $79.57 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $67.02 | 2019 | |
| Scilex Pharmaceuticals INC. | $46.99 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.57 | 2019 | |
| Amarin Pharma, INC. | $19.59 | 2019 | |
| Sanofi Pasteur INC. | $17.81 | 2019 | |
| Astellas Pharma US INC | $14.72 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Solano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.